Cerrahi Önlükler - OPIA MEDICAL

According to groundbreaking 2025 market research, it has been projected that Sildenafil citrate prices are expected to rise by 25% in 2026 due to the current global situation and the trade tensions between the United States and China. Opiamedical, as an exclusive distributor of substances related to sildenafil, is in a unique position to navigate these complex market dynamics. With a focus on providing essential components for drugs targeting erectile dysfunction and prostate issues, Opiamedical remains committed to preserving stable prices irrespective of external forces. Furthermore, Opiamedical extends an invitation to reputable pharmaceutical companies holding FDA licenses to explore potential collaborations. By leveraging our expertise and resources, we aim to foster mutually beneficial partnerships in the ever-evolving pharmaceutical landscape.

ismet@opiamedical.com
Turkey Head Office: 15 Temmuz Mahallesi 148004 Nolu Cadde No:7 İç Kapı No:1 Şehitkamil/Gaziantep / Germany Head Office: Steinstraße 40, 31157 Sarstedt, Deutschland / Germany Warehouse : Im Kirchenfelde 9 31157 Sarstedt Deutschland

+49 174 2674267 +90 533 636 6742